Skip to content
Disclosery

Hillview Capital Advisors, LLC

Follow

13F filer, CIK 1631615, Wayne, PA

Hillview Capital Advisors, LLC reported $16,601,000 across 4 holdings for the quarter ended 2018-12-31, in a 13F-HR filed 2019-02-01.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-19-000283

Period
2018-12-31
Reported value
$16.6M
Holdings
4
Top 10 weight
100%
New
1
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
Allegiance Bancsharesnew+6,500$210K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VEAreduced-144,297-$5.35M
AMZNexited-113-$226K
VIGexited-1,919-$213K
VTreduced-329-$21.5K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2018

Share positions as resolved from 13F-HR 0001172661-19-000283, largest first. % of portfolio is the value over $16,601,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
VEAVANGUARD TAX-MANAGED FDSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: 359,298 shares; 2017Q4: 359,704 shares; 2018Q1: 449,249 shares; 2018Q2: 453,506 shares; 2018Q3: 449,622 shares; 2018Q4: 305,325 shares 305,325$11.3M68.24%-144,297Timeline
VTVANGUARD INTL EQUITY INDEX FQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: 90,362 shares; 2017Q4: 88,009 shares; 2018Q1: 77,638 shares; 2018Q2: 77,117 shares; 2018Q3: 76,983 shares; 2018Q4: 76,654 shares 76,654$5.02M30.23%-329Timeline
Allegiance BancsharesAllegiance BancsharesQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: not reported; 2017Q4: not reported; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 6,500 shares 6,500$210K1.26%new
INNOVATE BIOPHARMACEUTICLS IINNOVATE BIOPHARMACEUTICLS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: not reported; 2017Q4: not reported; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 19,610 shares; 2018Q4: 19,610 shares 19,610$45K0.27%0

Sold out in Q4 2018

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AMZNAMAZON COM INC113$226Kshares
VIGVANGUARD SPECIALIZED FUNDS1,919$213Kshares

How Q4 2018 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-19-000283 base2019-02-01acceptance time not in the bulk data set